Electroencephalogram findings in patients with posterior cortical atrophy

Aim of the study: The aim of this study is to evaluate standard scalp EEG findings in patients with posterior cortical atrophy (PCA), an atypical variant of Alzheimer's disease (AD). Clinical rationale: PCA is a topographically selective variant of AD. Patients with typical AD have an increased likelihood of seizures, which may negatively impact overall functional performance and cognition. It is currently unknown what the typical EEG findings are for patients with PCA. Materials and methods: A retrospective chart review was performed on patients identified either with autopsy confirmed (n = 13) or clinically (n = 126) as PCA. Results: 139 patients were included though only 23 (16.5%) had undergone EEG recording. The EEG was normal in 6 (26%), while an abnormal EEG was present in 17 (74%). Interictal epileptic discharges (IEDs) were found in 2 of the 23 patients (9%). Conclusions: This study of limited sample size suggests that there may be an increased predilection to find IEDs within PCA when compared to typical AD. Larger cohorts are required to determine frequency of abnormal EEGs in PCA, roles of AEDs in therapy, and in the selection of preferred AED. Clinical implications: Patients with PCA would potentially benefit from an EEG for assessment of IEDs which may provide the clinician with a therapeutic opportunity

Crew Exploration Vehicle Environmental Control and Life Support Development Status

The Orion Crew Exploration Vehicle (CEV) is the first crew transport vehicle to be developed by the National Aeronautics and Space Administration (NASA) in the last thirty years. The CEV is currently being developed to transport the crew safely from the Earth to the Moon and back again. This year, the vehicle focused on building the Orion Flight Test 1 (OFT1) vehicle to be launched in 2013. The development of the Orion Environmental Control and Life Support (ECLS) System, focused on the components which are on OFT1 which includes pressure control and active thermal control systems, is progressing through the design stage into manufacturing. Additional development work was done to keep the remaining component progressing towards implementation. This paper covers the Orion ECLS development from April 2010 to April 2011

Evaluating the Applicability of Heritage Flight Hardware in Orion Environmental Control and Life Support Systems

Recent changes in the overall NASA vision has resulted in further cost and schedule challenges for the Orion program. As a result, additional scrutiny has been focused on the use of new developments for hardware in the environmental control and life support systems. This paper will examine the Orion architecture as it is envisioned to support missions to the International Space Station and future exploration missions and determine what if any functions can be satisfied through the use of existing, heritage hardware designs. An initial evaluation of each component is included and where a heritage component was deemed likely further details are examined. Key technical parameters, mass, volume and vibration loads are a few of the specific items that are evaluated. Where heritage hardware has been identified that may be substituted in the Orion architecture a discussion of key requirement changes that may need to be made as well as recommendation to further evaluate applicability are noted

Orion Multi Purpose Crew Vehicle Environmental Control and Life Support Development Status

The Orion Multi Purpose Crew Vehicle (MPCV) is the first crew transport vehicle to be developed by the National Aeronautics and Space Administration (NASA) in the last thirty years. Orion is currently being developed to transport the crew safely from the Earth beyond Earth orbit. This year, the vehicle focused on building the Exploration Flight Test 1 (EFT1) vehicle to be launched in 2014. The development of the Orion Environmental Control and Life Support (ECLS) System, focused on the components which are on EFT1 which includes pressure control and active thermal control systems, is progressing through the design stage into manufacturing. Additional development work was done to keep the remaining component progressing towards implementation for a flight tests in 2017 and in 2020. This paper covers the Orion ECLS development from April 2011 to April 2012

Protocol for the Northern Manhattan Diabetes Community Outreach Project. A randomised trial of a community health worker intervention to improve diabetes care in Hispanic adults

ObjectiveHispanics in the USA are affected by the diabetes epidemic disproportionately, and they consistently have lower access to care, poorer control of the disease and higher risk of complications. This study evaluates whether a community health worker (CHW) intervention may improve clinically relevant markers of diabetes care in adult underserved Hispanics.Methods and analysisThe Northern Manhattan Diabetes Community Outreach Project (NOCHOP) is a two-armed randomised controlled trial to be performed as a community-based participatory research study performed in a Primary Care Setting in Northern Manhattan (New York City). 360 Hispanic adults with poorly controlled type 2 diabetes mellitus (haemoglobin A1c >8%), aged 35–70 years, will be randomised at a 1:1 ratio, within Primary Care Provider clusters. The two study arms are (1) a 12-month CHW intervention and (2) enhanced usual care (educational materials mailed at 4-month intervals, preceded by phone calls). The end points, assessed after 12 months, are primary = haemoglobin A1c and secondary = blood pressure and low-density lipoprotein-cholesterol levels. In addition, the study will describe the CHW intervention in terms of components and intensity and will assess its effects on (1) medication adherence, (2) medication intensification, (3) diet and (4) physical activity.Ethics and disseminationAll participants will provide informed consent; the study protocol has been approved by the Institutional Review Board of Columbia University Medical Center. CHW interventions hold great promise in improving the well-being of minority populations who suffer from diabetes mellitus. The NOCHOP study will provide valuable information about the efficacy of those interventions vis-à-vis clinically relevant end points and will inform policy makers through a detailed characterisation of the programme and its effects.Clinical trial registration numberNCT00787475 at clinicaltrials.gov

Structural Ceramics by Fused Deposition of Ceramics

Fused Deposition of Ceramics (FDC) is a SFF technique, based on FDMTM technology, for fabrication of advanced structural ceramics from powderlbinder filaments. In this study, in-situ reinforced (ISR) Si3N4 powder and polymer/wax based binder systems were used as filament material for FDC processing using a commercially available FDMTM system, 3D Modeler. Powderlbinder feedstocks were mixed using a torque rheometer and filaments were fabricated using a capillary rheometer and twin screw extruder. Green FDC components were built from these filaments and then characterized for inter-road and inter-layer bonding. Binder removal procedures were established for FDC green components to yield brown parts without distortion or shape change. Brown FDC parts were characterized for carbon residue, pore distribution and dimensional changes. Brown FDC parts were then sintered and the sintered density, microstructure, and shrinkage anisotropy were studied.Mechanical Engineerin

An inhibitory circuit from central amygdala to zona incerta drives pain-related behaviors in mice

Central amygdala neurons expressing protein kinase C-delta (CeA-PKCδ) are sensitized following nerve injury and promote pain-related responses in mice. The neural circuits underlying modulation of pain-related behaviors by CeA-PKCδ neurons, however, remain unknown. In this study, we identified a neural circuit that originates in CeA-PKCδ neurons and terminates in the ventral region of the zona incerta (ZI), a subthalamic structure previously linked to pain processing. Behavioral experiments show that chemogenetic inhibition of GABAergic ZI neurons induced bilateral hypersensitivity in uninjured mice and contralateral hypersensitivity after nerve injury. In contrast, chemogenetic activation of GABAergic ZI neurons reversed nerve injury-induced hyper-sensitivity. Optogenetic manipulations of CeA-PKCδ axonal terminals in the ZI further showed that inhibition of this pathway reduces nerve injury-induced hypersensitivity whereas activation of the pathway produces hypersensitivity in the uninjured paws. Altogether, our results identify a novel nociceptive inhibitory efferent pathway from CeA-PKCδ neurons to the ZI that bidirectionally modulates pain-related behaviors in mice.Fil: Singh, Sudhuman. National Center For Complementary And Integrative Health; Estados UnidosFil: Wilson, Torri D.. National Center For Complementary And Integrative Health; Estados UnidosFil: Valdivia Torres, Lesly Spring. National Center For Complementary And Integrative Health; Estados Unidos. Consejo Nacional de Investigaciones Científicas y Técnicas; ArgentinaFil: Benowitz, Barbara. National Center For Complementary And Integrative Health; Estados UnidosFil: Chaudhry, Sarah. National Center For Complementary And Integrative Health; Estados UnidosFil: Ma, Jun. National Center For Complementary And Integrative Health; Estados UnidosFil: Adke, Anisha P.. National Center For Complementary And Integrative Health; Estados UnidosFil: Soler Cedeño, Omar. National Center For Complementary And Integrative Health; Estados UnidosFil: Velasquez, Daniela. National Center For Complementary And Integrative Health; Estados UnidosFil: Penzo, Mario A.. National Center For Complementary And Integrative Health; Estados UnidosFil: Carrasquillo, Yarimar. National Center For Complementary And Integrative Health; Estados Unido

"It's making contacts" : notions of social capital and implications for widening access to medical education

Acknowledgements Our thanks to the Medical Schools Council (MSC) of the UK for funding Study A; REACH Scotland for funding Study B; and Queen Mary University of London, and to the medical school applicants and students who gave their time to be interviewed. Our thanks also to Dr Sean Zhou and Dr Sally Curtis, and Manjul Medhi, for their help with data collection for studies A and B respectively. Our thanks also to Dr Lara Varpio, Uniformed Services University of the USA, for her advice and guidance on collating data sets and her comments on the draft manuscript.Peer reviewedPublisher PD